ArriVent BioPharma Reports First Quarter 2026 Financial Results

Go back to ArriVent BioPharma Reports First Quarter 2026 Financial Results
(NASDAQ: AVBP) Delayed: 13.49 +0.47 (3.61%)
Previous Close $13.02    52 Week High $ 
Open $13.39    52 Week Low $ 
Day High $13.57    P/E N/A 
Day Low $12.47    EPS $ 
Volume 1,859,288